Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neuroreport

Showing results (1221-1230 of 13,030) with videos related to

Pageof 1,303
Sort By:
Neuroreport|January 6, 1999
Lipopolysaccharide, central in vivo biogenic amine variations, and anhedoniaT Borowski, L Kokkinidis, Z Merali, et al.
Neuroreport|January 6, 1999
Mismatch negativity: deviance detection or the maintenance of the 'standard'I Winkler, I Czigler
Neuroreport|January 6, 1999
Three-dimensional modeling of static vestibulo-ocular brain stem syndromesS Glasauer, M Dieterich, T Brandt
Neuroreport|January 6, 1999
COX-2 inhibitor prevents the development of hyperalgesia induced by intrathecal NMDA or AMPAT Yamamoto, Y Sakashita
Neuroreport|January 6, 1999
Are aminoglycoside antibiotics excitotoxic?S H Sha, J Schacht
Neuroreport|January 6, 1999
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist actionF X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, et al.
Neuroreport|January 6, 1999
Enhanced AP-1 binding in brain induced by D1 and D2 agonists in methamphetamine-sensitized ratsT Ishihara, K Akiyama, K Kashihara
Neuroreport|January 6, 1999
MK-801 and male odours induce c-fos expression in the AOB of juvenile female miceR A McLellan, M Wilkinson, R E Brown
Neuroreport|January 6, 1999
Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies casesO M El-Agnaf, M D Curran, A Wallace, et al.
Neuroreport|January 6, 1999
Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in ratsA Monopoli, G Lozza, A Forlani, et al.
Pageof 1,303

Showing results (1221-1230 of 13,030) with videos related to

Sort By:
Pageof 1,303
Neuroreport|January 6, 1999
Lipopolysaccharide, central in vivo biogenic amine variations, and anhedoniaT Borowski, L Kokkinidis, Z Merali, et al.
Neuroreport|January 6, 1999
Mismatch negativity: deviance detection or the maintenance of the 'standard'I Winkler, I Czigler
Neuroreport|January 6, 1999
Three-dimensional modeling of static vestibulo-ocular brain stem syndromesS Glasauer, M Dieterich, T Brandt
Neuroreport|January 6, 1999
COX-2 inhibitor prevents the development of hyperalgesia induced by intrathecal NMDA or AMPAT Yamamoto, Y Sakashita
Neuroreport|January 6, 1999
Are aminoglycoside antibiotics excitotoxic?S H Sha, J Schacht
Neuroreport|January 6, 1999
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist actionF X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, et al.
Neuroreport|January 6, 1999
Enhanced AP-1 binding in brain induced by D1 and D2 agonists in methamphetamine-sensitized ratsT Ishihara, K Akiyama, K Kashihara
Neuroreport|January 6, 1999
MK-801 and male odours induce c-fos expression in the AOB of juvenile female miceR A McLellan, M Wilkinson, R E Brown
Neuroreport|January 6, 1999
Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies casesO M El-Agnaf, M D Curran, A Wallace, et al.
Neuroreport|January 6, 1999
Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in ratsA Monopoli, G Lozza, A Forlani, et al.
Pageof 1,303